American Portfolios Advisors Repligen Corp Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Repligen Corp stock. As of the latest transaction made, American Portfolios Advisors holds 1,166 shares of RGEN stock, worth $168,440. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,166
Holding current value
$168,440
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$160.42 - $256.21 $187,049 - $298,740
1,166 New
1,166 $218 Million
Q2 2022

Mar 20, 2023
SELL
$140.68 - $188.02 $281 - $376
-2 Reduced 0.17%
1,164 $189 Million
Q1 2022

Mar 21, 2023
BUY
$161.19 - $257.96 $290,625 - $465,101
1,803 Added 154.63%
2,969 $558 Million
Q4 2021

Mar 21, 2023
BUY
$247.59 - $304.47 $783,127 - $963,038
3,163 Added 271.27%
4,329 $1.15 Billion
Q3 2021

Mar 22, 2023
BUY
$194.77 - $324.21 $268,782 - $447,409
1,380 Added 118.35%
2,546 $736 Million
Q2 2021

Mar 22, 2023
SELL
$165.87 - $220.95 $152,102 - $202,611
-917 Reduced 78.64%
249 $49.7 Million
Q1 2021

Mar 22, 2023
BUY
$180.37 - $226.26 $433,970 - $544,381
2,406 Added 206.35%
3,572 $694 Million
Q4 2020

Mar 22, 2023
BUY
$148.08 - $206.57 $391,671 - $546,377
2,645 Added 226.84%
3,811 $730 Million
Q3 2020

Mar 22, 2023
BUY
$122.51 - $158.27 $133,290 - $172,197
1,088 Added 93.31%
2,254 $333 Million
Q2 2020

Mar 24, 2023
BUY
$94.33 - $140.48 $49,617 - $73,892
526 Added 18.7%
3,339 $413 Million
Q1 2020

Mar 24, 2023
BUY
$84.96 - $109.14 $139,929 - $179,753
1,647 Added 141.25%
2,813 $272 Million
Q4 2019

Mar 24, 2023
SELL
$73.84 - $93.08 $80,116 - $100,991
-1,085 Reduced 93.05%
81 $7.49 Million
Q3 2019

Mar 24, 2023
SELL
$76.65 - $95.51 $83,165 - $103,628
-1,085 Reduced 93.05%
81 $6.21 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email